- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03202069
Protein Eating Patterns and Weight Loss
October 30, 2023 updated by: Shanon Casperson, USDA Grand Forks Human Nutrition Research Center
Effect of Daily Protein Intake Patterns During Weight Loss on Dietary Adherence and Body Composition in Women
The purpose of this study is to determine the effects of daily protein intake patterns on body composition and eating behaviors during weight loss.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The reinforcing value of food varies greatly among individuals, but is strongest for those who are overweight or obese.
Reducing energy intake, which is necessary for overweight and obese individuals to achieve a healthier body weight, increases the reinforcing value of food - especially for energy-dense snack foods.
Food is a powerful reinforcer and is associated with energy intake; making it a primary contributing factor to an individual's weight loss struggle.
Developing a way to decrease or limit the increase in food reinforcement during energy deficits would have important clinical impact.
High-protein diets are known to be efficacious for weight loss and recently have been shown to decrease stimulation of the reward areas of the brain that stimulate reward-driven eating behavior.
Nonetheless, sustaining a high-protein diet can be difficult, especially for women.
Consuming a modest amount of protein at each meal may be better tolerated.
However, we do not know whether this pattern of protein intake can assist women in staying "on track" with weight loss goals.
This study will help begin to elucidate the connections between the daily pattern of protein intake on diet adherence, alterations in food reinforcement, and favorable body composition changes during weight loss.
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Dakota
-
Grand Forks, North Dakota, United States, 58203
- USDA Grand Forks Human Nutrition Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 44 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- BMI 28-45 kg/m2
Exclusion Criteria:
- unable or unwilling to consume animal products
- unable or unwilling to attend treatment group meetings
- had more than a 10% change in body weight in the 2 months prior to study start date
- consuming a specialized diet
- have a history of and eating or gastrointestinal disorder
- currently or planning on becoming pregnant during the study timeline
- lactating
- have an uncontrolled metabolic illness/disease (fasting glucose >125 mg/dL)
- have uncontrolled hypertension (>160/99 mm Hg)
- have cancer or in short-term remission (less than 3 years)
- have an infectious disease
- suffer from alcohol or drug abuse
- use tobacco and/or e-cigarette products on a regular basis
- taking medications known to affect energy expenditure and appetite
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Even protein intake
Menu to provide 90 g of protein per day in an even distribution of 30 g at each meal.
|
Intake of even protein 5 day rotating menu
|
Experimental: Skewed protein intake
Menu to provide 90 g of protein per day in a skewed distribution of 10 g at breakfast, 15 g at lunch and 65 g at dinner.
|
Intake of skewed protein 5 day rotating menu
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body Composition
Time Frame: 8 and 16 weeks
|
Determine the effects of two patterns of daily protein intake on changes in fat mass and fat-free mass during weight loss.
|
8 and 16 weeks
|
Diet Adherence
Time Frame: 16 weeks
|
Determine the effects of two patterns of daily protein intake on weight loss diet adherence and putative mediators (satisfaction, satiety, hunger, and reinforcing value of energy dense foods) of adherence.
|
16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Barriers to weight control
Time Frame: 1 hour
|
Nominal Group Technique results providing an exhaustive list of barriers to weight control in overweight and obese women
|
1 hour
|
Change in skeletal muscle protein breakdown
Time Frame: 8 and 16 weeks
|
The effect of consuming two patterns of daily protein intake on 3-Methylhistidine degradation, a biochemcial marker of skeletal muscle protein breakdown
|
8 and 16 weeks
|
Circulating carotenoid levels
Time Frame: 8 and 16 weeks
|
The effect of consuming two patterns of protein intake during weight loss on circulating carotenoid levels.
|
8 and 16 weeks
|
Relative reinforcing value (RRV) of food
Time Frame: 8 and 16 weeks
|
The effect of consuming two patterns of daily protein intake during weight loss on the RRV of energy-dense snack food
|
8 and 16 weeks
|
Change in bone turnover
Time Frame: 8 and 16 weeks
|
The effect of consuming two patterns of daily protein intake during weight loss on osteocalcin, alkaline phosphatase, acid phosphatase, and collagen cross-link molecules -- biochemical markers of bone formation and resorption
|
8 and 16 weeks
|
Plasma lipids
Time Frame: 8 and 16 weeks
|
The effect of consuming two patterns of daily protein intake during weight loss on lipid and triglyceride molecular speciation.
|
8 and 16 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Shanon Casperson, PhD, USDA Grand Forks Human Nutrition Research Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 2, 2017
Primary Completion (Actual)
April 14, 2023
Study Completion (Actual)
April 14, 2023
Study Registration Dates
First Submitted
June 26, 2017
First Submitted That Met QC Criteria
June 26, 2017
First Posted (Actual)
June 28, 2017
Study Record Updates
Last Update Posted (Actual)
November 2, 2023
Last Update Submitted That Met QC Criteria
October 30, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GFHNRC510
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Even protein
-
University of Missouri-ColumbiaNational Cattlemen's Beef AssociationCompletedObesity | Poor Glycemic Control | Dietary Interventions
-
USDA Grand Forks Human Nutrition Research CenterActive, not recruitingObesityUnited States
-
University of ArkansasCompleted
-
Brigham and Women's HospitalTerminatedArthralgia | Trouble BalancingUnited States
-
Purdue UniversityDairy Research Institute; National Cattlemen's Beef Association; American Egg... and other collaboratorsCompletedParesis | Body Composition, Beneficial | Impaired Glucose ToleranceUnited States
-
Istanbul Medipol University HospitalSaremco Dental AGRecruitingDental Prosthesis | Composite ResinsTurkey
-
UnitedHealth GroupMayo Clinic; Bill and Melinda Gates Foundation; PATHCompletedSARS-CoV InfectionUnited States
-
Region ÖstergötlandUnknownChlamydia Trachomatis Genital Infection | Chlamydia Trachomatis Infection of Anus and RectumSweden
-
Assistance Publique - Hôpitaux de ParisRecruitingIntrauterine Growth Restriction | Fetal Growth Restriction (FGR)France
-
Fudan UniversityHenan Cancer HospitalCompletedMetastatic Colorectal Cancer | Chemotherapy EffectChina